Related Experiment Video
Updated: Jun 26, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries
Stefano Cagnin1, Michele Biscuola, Cristina Patuzzo
1CRIBI Biotechnology Centre, University of Padova, Padova, Italy. stefanoc@cribi.unipd.it
Insights
Atherosclerosis involves inflammation and specific gene pathways like JAK/STAT. This study identifies key genes and proteins, such as S100A9/S100A8 and caveolae system components, crucial for vascular disease progression.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Genomics
Background:
- Atherosclerosis commonly affects major arteries, with circulating factors potentially mediating plaque rupture and thrombosis.
- Understanding common molecular pathways is crucial for addressing this widespread vascular disease.
Purpose of the Study:
- To investigate how calcified plaque presence alters gene expression in human coronary and carotid arteries.
- To identify atherogenic genes and their functional networks involved in vascular disease.
Main Methods:
- Utilized DNA microarrays and meta-analysis to compare gene expression in atherosclerotic plaques.
- Analyzed plasma levels of cytokines, chemokines, and growth factors in patients.
Main Results:
- Identified key atherogenic genes and functional networks, including caveolae, JAK/STAT pathways, and S100A9/S100A8 proteins.
- Found elevated levels of various cytokines (e.g., IL-6, VEGF) and chemokines in atherosclerotic patients' plasma.
- Demonstrated connections between caveolae, hormone receptors, and apoptosis pathways.
Conclusions:
- Atherosclerosis is characterized as a proinflammatory disorder due to cytokine and S100A9/S100A8 up-regulation.
- JAK/STAT pathway activation is confirmed by gene up-regulation in plaques.
- STAT proteins and the caveolae system play central roles in plaque preservation, with Cav-1 impacting SMC differentiation and lipid homeostasis.
Background:
Atherosclerosis affects aorta, coronary, carotid, and iliac arteries most frequently than any other body vessel. There may be common molecular pathways sustaining this process. Plaque presence and diffusion is revealed by circulating factors that can mediate systemic reaction leading to plaque rupture and thrombosis.
Results:
We used DNA microarrays and meta-analysis to study how the presence of calcified plaque modifies human coronary and carotid gene expression. We identified a series of potential human atherogenic genes that are integrated in functional networks involved in atherosclerosis. Caveolae and JAK/STAT pathways, and S100A9/S100A8 interacting proteins are certainly involved in the development of vascular disease. We found that the system of caveolae is directly connected with genes that respond to hormone receptors, and indirectly with the apoptosis pathway. Cytokines, chemokines and growth factors released in the blood flux were investigated in parallel. High levels of RANTES, IL-1ra, MIP-1 alpha, MIP-1 beta, IL-2, IL-4, IL-5, IL-6, IL-7, IL-17, PDGF-BB, VEGF and IFN-gamma were found in plasma of atherosclerotic patients and might also be integrated in the molecular networks underlying atherosclerotic modifications of these vessels.
Conclusion:
The pattern of cytokine and S100A9/S100A8 up-regulation characterizes atherosclerosis as a proinflammatory disorder. Activation of the JAK/STAT pathway is confirmed by the up-regulation of IL-6, STAT1, ISGF3G and IL10RA genes in coronary and carotid plaques. The functional network constructed in our research is an evidence of the central role of STAT protein and the caveolae system to contribute to preserve the plaque. Moreover, Cav-1 is involved in SMC differentiation and dyslipidemia confirming the importance of lipid homeostasis in the atherosclerotic phenotype.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management

